Related Experiment Video
Updated: Sep 23, 2026
Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel
Published on: June 29, 2015
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor
1Institut National de la Santé et de la Recherche Médicale (INSERM) U.311, Etablissement Français du Sang, Alsace (EFS-Alsace), 10 rue Spielmann, BP no. 36, 67065 Strasbourg Cédex, France.
Abstract:
Previous studies in experimental models revealed a role for the P2Y1 platelet ADP receptor in systemic vascular thromboembolism models. In the present work, we used models of localized arterial and venous thrombosis to assess the role of the P2Y1 receptor in these processes. Arterial thrombosis was induced in one mesenteric arteriole of a mouse using FeCl3, while venous thrombosis was studied in a Wessler model adapted to rats. P2Y1-deficient mice and mice treated with the P2Y1 antagonist MRS2179 displayed significantly less arterial thrombosis than their respective controls. Combination of P2Y1 deficiency with P2Y12 inhibition led to a significant additive effect. Venous thrombosis was slightly but significantly inhibited in MRS2179-treated rats. These results demonstrate a role for the P2Y1 receptor in both arterial and venous thrombosis, further establishing this receptor as a potential target for antithrombotic drugs.
Insights
The P2Y1 receptor plays a key role in both arterial and venous thrombosis. Inhibiting this platelet ADP receptor shows potential for developing new antithrombotic drugs.
Area of Science:
- Pharmacology
- Hematology
- Cardiovascular Research
Background:
- The P2Y1 platelet ADP receptor is implicated in systemic vascular thromboembolism.
- Its role in localized arterial and venous thrombosis requires further investigation.
Purpose of the Study:
- To evaluate the function of the P2Y1 receptor in localized arterial and venous thrombosis models.
- To assess the therapeutic potential of targeting the P2Y1 receptor for antithrombotic strategies.
Main Methods:
- Arterial thrombosis induced in mouse mesenteric arterioles using FeCl3.
- Venous thrombosis studied in a rat Wessler model.
- Utilized P2Y1-deficient mice and P2Y1 antagonist MRS2179 treatment.
Main Results:
- P2Y1 deficiency and MRS2179 significantly reduced arterial thrombosis.
- Combined P2Y1 deficiency and P2Y12 inhibition showed an additive antithrombotic effect.
- MRS2179 treatment resulted in significant inhibition of venous thrombosis.
Conclusions:
- The P2Y1 receptor is involved in both arterial and venous thrombosis.
- P2Y1 receptor antagonism is a promising strategy for antithrombotic drug development.
